GFAP and central nervous system cancer: Another group reported an upregulation of the astrocyte marker glial fibrillary acidic protein (GFAP) and a downregulation of the mesenchymal marker vimentin as well as reduced proliferation of glioma cell lines upon Notch inhibition (88).